h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
How-To Videos
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
HIHDNEi002-A
Registration Summary
:
A
P
E
C
The cell line is
not submitted
yet.
(only basic data is shown)
General
iPSC Line
hPSCreg name
HIHDNEi002-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
HIHDNEi002-A (RRID:CVCL_WN13)
iPSC line type
Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines
No similar lines found.
Last update
28th May 2018
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Department of Neurology and Epileptology, Hertie Institute for Clinical Brain Research, University of Tuebingen (HIHDNE)
External iPSC Databases
Cellosaurus
CVCL_WN13
Wikidata
Q94208329
General iPSC Information
Publications
Schwarz N et al. Establishment of a human induced pluripotent stem cell (iPSC) line (HIHDNEi002-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Arg297Gln) mutation. Stem cell research. 2019 May;37:101445.
Uysal B et al. Generation of an induced pluripotent stem cell (iPSC) line (HIHDNEi003-A) from a patient with developmental and epileptic encephalopathy carrying a KCNA2 (p.Thr374Ala) mutation. Stem cell research. 2019 Oct;40:101543.
D'Adamo MC et al. Ion Channels Involvement in Neurodevelopmental Disorders. Neuroscience. 2020 Aug 1;440:337-359.
Hirose S et al. Application of induced pluripotent stem cells in epilepsy. Molecular and cellular neurosciences. 2020 Oct;108:103535.
Döring JH et al. Refining Genotypes and Phenotypes in KCNA2-Related Neurological Disorders. International journal of molecular sciences. 2021 Mar 10;22(6).
Imbrici P et al. A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine. International journal of molecular sciences. 2021 Sep 14;22(18).
Weng OY et al. Modeling Epilepsy Using Human Induced Pluripotent Stem Cells-Derived Neuronal Cultures Carrying Mutations in Ion Channels and the Mechanistic Target of Rapamycin Pathway. Frontiers in molecular neuroscience. 2022;15:810081.
Javaid MS et al. Human In Vitro Models of Epilepsy Using Embryonic and Induced Pluripotent Stem Cells. Cells. 2022 Dec 7;11(24).
Park Sangbae et al. Engineering considerations of iPSC-based personalized medicine. Biomaterials Research. 2023-02-09.
Xie Changning et al. Roles of KCNA2 in Neurological Diseases: from Physiology to Pathology. Molecular Neurobiology. 2024-11-00.
iPSC Derivation
General
Login to share your feedback, experiences or results with the research community.